Tradestie Institutional Equity Comparison Engine

CELC vs ABVX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVX Overall Edge

ABVX Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abivax SA American Depositary Shares (ABVX) driven by superior Momentum & Technical, Options & Structure while CELC counters with relative strength in Growth & Margin. Fundamentally, CELC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABVX at N/M Forward P/E and -6270.4% operating margin (-6.8% YoY). In options structure, CELC sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro) against ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CELC N/M vs ABVX N/M Fwd P/E
Growth & Margin Winner CELC
Op Margin 0.0% vs -6270.4% ยท YoY +0.0% vs -6.8%
Momentum & Technical Winner ABVX
1Y -28.7% vs -17.7% ยท 52W Pos 8% vs 17%
Options & Structure Winner ABVX
BREAKDOWN (30th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
CELC NASDAQ
Celcuity Inc. Common Stock
Services-Medical Laboratories
$61.31
-4.75% 1D
Market Cap $3.2B
1M Return +8.36%
1Y Return -28.71%
Forward P/E N/M
Unified AI Score
39.7 / 100 SELL
Tech 25.0 Fund 43.0 Flow 59.0 Mom 64.0
ABVX NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$83.06
-5.17% 1D
Market Cap $7.9B
1M Return -5.76%
1Y Return -17.69%
Forward P/E N/M
Unified AI Score
55.6 / 100 HOLD
Tech 42.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CELC -28.71% ABVX -17.69% Spread: +11.02 pp (ABVX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CELC TTM Op. Margin: 0.0% ABVX TTM Op. Margin: -6270.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CELC vs ABVX. Trailing 12-month operating profitability (CELC 0.0% vs ABVX -6270.4%) and valuation multiples (CELC N/M vs ABVX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CELC (2) vs ABVX (5)
Institutional Metric CELC ABVX Criterion Row Winner
Market Capitalization Scale $3.2B $7.9B Larger Scale ABVX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -6.8% Higher Growth CELC
Operating Margin (TTM) Profitability 0.0% -6270.4% Higher Margin CELC
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1192.9% -252.3% Higher ROE ABVX
52-Week Range Position Momentum 8% ($54โ€“$151) 17% ($70โ€“$149) Stronger Trend ABVX
Beta / 30D Volatility Risk Regime 1.28ฮฒ ยท 60% Vol 1.38ฮฒ ยท 48% Vol Lower Realized Risk ABVX
Unified Institutional Score Composite Signal 39.7 / 100 (SELL) 55.6 / 100 (HOLD) Higher Composite ABVX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CELC vs ABVX Buy Guide
CELC BREAKDOWN
136d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CELC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABVX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ABVX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CELC nor ABVX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.